Vasopressin regulates the renal Na + -Cl − cotransporter
2009; American Physical Society; Volume: 298; Issue: 3 Linguagem: Inglês
10.1152/ajprenal.00723.2009
ISSN1931-857X
Autores Tópico(s)Renal function and acid-base balance
ResumoEDITORIAL FOCUSVasopressin regulates the renal Na+-Cl− cotransporterGerardo GambaGerardo GambaMolecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoPublished Online:01 Mar 2010https://doi.org/10.1152/ajprenal.00723.2009This is the final version - click for previous versionMoreSectionsPDF (41 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat the renal thiazide-sensitive Na+-Cl− cotransporter (NCC) is the major salt reabsorption pathway in the distal convoluted tubule (DCT), a region of the nephron that is located beyond the macula densa. Because of this location, salt reabsorption in DCT is not subjected to the tubular-glomerular balance mechanism, affecting the final concentration of salt in urine and, thus, arterial blood pressure. Additionally, salt reabsorption in DCT is essential to define the amount of salt delivery to the collecting duct, which is required for the Na+/K+ exchange between the epithelial Na+ channel (ENaC) and the apical K+ channels ROMK and BK to promote K+ secretion regulation. These roles of NCC in blood pressure and K+ secretion regulation have been demonstrated extensively. On one hand, inactivating mutations of the SLC12A3 gene encoding NCC produce Gitelman's disease that features arterial hypotension and hypokalemia. On the other hand, dysregulation of NCC by mutations in the with-no-lysine serine/threonine kinases WNK1 and WNK4 is the major mechanism producing arterial hypertension and hyperkalemia in pseudohypoaldosteronism type II (10). Thus NCC activity is critical to define arterial blood pressure levels and K+ secretion; therefore, a lot of attention has been given in the last years to regulatory mechanisms of this cotransporter. It is widely accepted that NCC is regulated by both aldosterone and ANG II. Aldosterone modulates NCC activity by increasing its expression (9). This is an effect that is likely to be more important for DCT2, rather than DCT1, since the early DCT lacks expression of 11β-hydroxysteroid dehydrogenase type 2 (11HSD2). ANG II, in contrast, is known to modulate NCC activity by promoting trafficking of NCC from intracellular vesicles to the plasma membrane (18), an effect that is expected to occur in both DCT1 and DCT2.It has been demonstrated in studies in vitro (13, 15, 16) and in vivo (1) that activity of NCC, mainly because of vesicular trafficking of the cotransporter to the plasma membrane, is associated with phosphorylation of the NH2-terminal domain threonines-53 and -58 and serine-71 in rat (55, 60, and 73 in human NCC). The same conserved sites become phosphorylated during activation of the Na+-K+-2Cl− cotransporters (NKCC1 and NKCC2) that are closely related to NCC (degree of identity 50%) (2, 3, 7, 14, 16). One of these studies demonstrated that acute vasopressin administration increased the phosphorylation of NKCC2 NH2-terminal domain threonines and its trafficking toward apical membrane (7). Activation/phosphorylation of all three cotransporters by different stimuli has been linked to signaling through at least two families of threonine/serine kinases (WNKs and the STE20 related kinases SPAK and OSR1). Evidences suggest that WNKs lie upstream of SPAK/OSR1 and that NKCC1/2 or NCC are actually phosphorylated in the conserved NH2-terminal threonines by SPAK/OSR1 (4, 6, 8, 14–17, 19, 20).One potential regulatory hormone for NCC is vasopressin. This nanopeptide hormone produced in hypothalamus and secreted in the posterior pituitary gland in response to increased plasma osmolarity or decreased blood pressure is very well known for its capacity to activate urinary concentration mechanisms and also to promote an increase in arterial pressure. Like many other hormones affecting blood pressure (ANG II, aldosterone, atrial natriuretic peptide, catecholamines, etc.), vasopressin does it by modulating both vascular smooth muscle contraction and urinary salt/water reabsorption. These effects are traduced in the smooth muscle and renal tubular cells through the Gα coupled receptors V1 and V2, respectively. In the kidney, vasopressin is known to modulate the activity of NKCC2, ENaC, and aquaporin 2. Its effects in DCT, however, have not been clearly demonstrated. Studies from Elalouf et al. (5) using micropuncture in homozygous diabetes insipidus (DI) Brattleboro rats strongly suggested that vasopressin increases salt reabsorption in DCT. Mutig et al. (11) demonstrated by in situ hybridization and immunohistochemistry of human, mouse, and rat kidney the presence of the V2 mRNA and protein in DCT1. The study of vasopressin on the NCC, however, has been limited by the absence of reliable cultured cell lines from DCT.In the American Journal of Physiology-Renal Physiology, the study of Mutig et al. (12) for the first time provides direct evidence of NCC regulation by vasopressin, taking advantage of the molecular tools that have been developed to study NCC regulation/phosphorylation. Short-term stimulation of NCC by vasopressin in physiological or pharmacological doses was assessed in DI Brattleboro rats 30 min after intraperitoneal injection of desmopressin (dDAVP). Using confocal microscopy, immunogold staining of NCC in electron microscopy analysis, and Western blot of vesicle-enriched fraction, the authors observed that dDAVP administration was associated with significant trafficking of NCC toward DCT apical plasma membrane. With the aid of phosphospecific antibodies recognizing phosphorylation of NCC threonine-53 or serine-71, it was demonstrated that dDAVP administration resulted in increased phosphorylation of these residues. Next, the authors observed that dDAVP was able to induce NCC serine-71 phosphorylation in renal tubule suspensions, suggesting that the vasopressin effect on DCT can be direct and not necessarily related to activation of other hormonal pathways. Finally, consistent with the previous observation that V2 receptors are more abundant in DCT1 than in DCT2 (11), it was observed that dDAVP-induced phosphorylation of NCC serine-71 was confined to DCT1, since 11HSD2-positive DCT2 cells showed no major change in pS71 NCC after dDAVP administration. Thus, although aldosterone seems to be a regulator of NCC in DCT2, vasopressin probably affects NCC activity only in DCT1, suggesting a fine tune of regulation of NCC in two different cells.The observations presented in the American Journal of Physiology-Renal Physiology by Mutig et al. (12) resolve with reasonable degree of certainty the question of the vasopressin effect on NCC activity. With these observations, it is now known that vasopressin modulates renal salt/urea/water transport all the way from the loop of Henle to the inner medullary collecting duct. Several issues rise with these observations that will be testable in the future. One is to find out if the vasopressin effect on NCC phosphorylation/trafficking also involves modulation of the WNKs-SPAK/OSR1 pathway. Phosphorylation of NCC and NKCCs in the conserved NH2-terminal threonines seems to be a common final pathway of several stimuli, including, for instance, intracellular Cl− depletion (2, 13, 14), WNKs (8, 16, 19, 21), SPAK (15), growth hormone (3), salt depletion/ANG II (1, 17), and vasopressin (7, 12). It is going to be interesting to find out if activation of a Gs-coupled receptor, like V2, can eventually modulate WNKs/SPAK interaction to phosphorylate NCC or if NH2-terminal threonines of NCC can be a target of another kinase. Another interesting issue to be resolved is to what extent the effect of vasopressin on NCC is solely by activation of the V2 receptor or if activation of other hormonal systems (perhaps ANG II, aldosterone, cortisol, catecholamines) is also involved. Finally, a third type of studies will be required to integrate the vasopressin effect on NCC to define the hierarchy of each of the components within the redundancy of the modulator mechanism.REFERENCES1. Chiga M , Rai T , Yang SS , Ohta A , Takizawa T , Sasaki S , Uchida S. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int 74: 1403–1409, 2008.Crossref | PubMed | ISI | Google Scholar2. Darman RB , Forbush B. A regulatory locus of phosphorylation in the N terminus of the Na-K-Cl cotransporter, NKCC1. J Biol Chem 277: 37542–37550, 2002.Crossref | PubMed | ISI | Google Scholar3. Dimke H , Flyvbjerg A , Bourgeois S , Thomsen K , Frokiaer J , Houillier P , Nielsen S , Frische S. Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2. Am J Physiol Renal Physiol 292: F723–F735, 2007.Link | ISI | Google Scholar4. Dowd BF , Forbush B. PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1). J Biol Chem 278: 27347–27353, 2003.Crossref | PubMed | ISI | Google Scholar5. Elalouf JM , Roinel N , de Rouffignac C. Effects of antidiuretic hormone on electrolyte reabsorption and secretion in distal tubules of rat kidney. Pflugers Arch 401: 167–173, 1984.Crossref | PubMed | ISI | Google Scholar6. Gagnon KB , England R , Delpire E. Volume sensitivity of cation-Cl- cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. Am J Physiol Cell Physiol 290: C134–C142, 2006.Link | ISI | Google Scholar7. Gimenez I , Forbush B. Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem 278: 26946–26951, 2003.Crossref | PubMed | ISI | Google Scholar8. Kahle KT , Rinehart J , De Los HP , Louvi A , Meade P , Vazquez N , Hebert SC , Gamba G , Gimenez I , Lifton RP. WNK3 modulates transport of Cl- in and out of cells: Implications for control of cell volume and neuronal excitability. Proc Natl Acad Sci USA 102: 16783–16788, 2005.Crossref | PubMed | ISI | Google Scholar9. Kim GH , Masilamani S , Turner R , Mitchell C , Wade JB , Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 95: 14552–14557, 1998.Crossref | PubMed | ISI | Google Scholar10. Lalioti MD , Zhang J , Volkman HM , Kahle KT , Hoffmann KE , Toka HR , Nelson-Williams C , Ellison DH , Flavell R , Booth CJ , Lu Y , Geller DS , Lifton RP. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38: 1124–1132, 2006.Crossref | PubMed | ISI | Google Scholar11. Mutig K , Paliege A , Kahl T , Jons T , Muller-Esterl W , Bachmann S. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 293: F1166–F1177, 2007.Link | ISI | Google Scholar12. Mutig K , Saritas T , Uchida S , Kahl T , Borowski T , Paliege A , Böhlick A , Bleich M , Shan Q , Bachmann S. Short-term stimulation of the thiazide-sensitive Na+-Cl– cotransporter by vasopressin involves phosphorylation and membrane translocation. Am J Physiol Renal Physiol. 298: F502–F509, 2010.Link | ISI | Google Scholar13. Pacheco-Alvarez D , San Cristobal P , Meade P , Moreno E , Vazquez N , Munoz E , Diaz A , Juarez ME , Gimenez I , Gamba G. The Na-Cl cotransporter is activated and phosphorylated at the amino terminal domain upon intracellular chloride depletion. J Biol Chem 281: 28755–28763, 2006.Crossref | PubMed | ISI | Google Scholar14. Ponce-Coria J , San Cristobal P , Kahle KT , Vazquez N , Pacheco-Alvarez D , De Los HP , Juarez P , Munoz E , Michel G , Bobadilla NA , Gimenez I , Lifton RP , Hebert SC , Gamba G. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci USA 105: 8458–8463, 2008.Crossref | PubMed | ISI | Google Scholar15. Richardson C , Rafiqi FH , Karlsson HK , Moleleki N , Vandewalle A , Campbell DG , Morrice NA , Alessi DR. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci 121: 675–684, 2008.Crossref | PubMed | ISI | Google Scholar16. Rinehart J , Kahle KT , De Los HP , Vazquez N , Meade P , Wilson FH , Hebert SC , Gimenez I , Gamba G , Lifton RP. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl170 cotransporters required for normal blood pressure homeostasis. Proc Natl Acad Sci USA 102: 16777–16782, 2005.Crossref | PubMed | ISI | Google Scholar17. San Cristobal P , Pacheco-Alvarez D , Richardson C , Ring AM , Vazquez N , Rafiqi FH , Chari D , Kahle KT , Leng Q , Bobadilla NA , Hebert SC , Alessi DR , Lifton RP , Gamba G. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci USA 106: 4384–4389, 2009.Crossref | PubMed | ISI | Google Scholar18. Sandberg MB , Riquier AD , Pihakaski-Maunsbach K , McDonough AA , Maunsbach AB. Angiotensin II provokes acute trafficking of distal tubule NaCl cotransporter (NCC) to apical membrane. Am J Physiol Renal Physiol 293: F662–F669, 2007.Link | ISI | Google Scholar19. Vitari AC , Deak M , Morrice NA , Alessi DR. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome, phosphorylate and active SPAK and OSR1 protein kinases. Biochem J 391: 17–24, 2005.Crossref | PubMed | ISI | Google Scholar20. Vitari AC , Thastrup J , Rafiqi FH , Deak M , Morrice NA , Karlsson HK , Alessi DR. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J 397: 223–231, 2006.Crossref | PubMed | ISI | Google Scholar21. Yang SS , Morimoto T , Rai T , Chiga M , Sohara E , Ohno M , Uchida K , Lin SH , Moriguchi T , Shibuya H , Kondo Y , Sasaki S , Uchida S. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 5: 331–344, 2007.Crossref | PubMed | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: G. Gamba, Vasco de Quiroga No. 15, Tlalpan 14000, Mexico City, Mexico (e-mail: [email protected]unam.mx or [email protected]innsz.mx). Download PDF Previous Back to Top Next FiguresReferencesRelatedInformation Cited ByThiazide-Sensitive NaCl Cotransporter5 March 2021Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic ratsKaori Takayanagi, Taisuke Shimizu, Yosuke Tayama, Akira Ikari, Naohiko Anzai, Takatsugu Iwashita, Juko Asakura, Keitaro Hayashi, Tetsuya Mitarai, and Hajime Hasegawa15 June 2015 | American Journal of Physiology-Renal Physiology, Vol. 308, No. 12The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defectsBlood, Vol. 123, No. 12Temporal delays and individual variation in antidiuretic response to desmopressinKristian Vinter Juul, Lars Erichsen, and Gary L. Robertson1 February 2013 | American Journal of Physiology-Renal Physiology, Vol. 304, No. 3Mechanisms of sodium–chloride cotransporter modulation by angiotensin IICurrent Opinion in Nephrology & Hypertension, Vol. 21, No. 5Molecular Physiology of the Medullary Collecting Duct1 April 2011 More from this issue > Volume 298Issue 3March 2010Pages F500-F501 Copyright & PermissionsCopyright © 2010 the American Physiological Societyhttps://doi.org/10.1152/ajprenal.00723.2009PubMed20042457History Published online 1 March 2010 Published in print 1 March 2010 Metrics
Referência(s)